Assessing and Overcoming Resistance Phenomena against a Genetically Modified Vaccinia Virus in Selected Cancer Cell Lines

Assessing and Overcoming Resistance Phenomena against a Genetically Modified Vaccinia Virus in Selected Cancer Cell Lines

Genetically modified vaccinia viruses (VACVs) have been shown to possess profound oncolytic capabilities. However, tumor cell resistance to VACVs may endanger broad clinical success. Using cell mass assays, viral replication studies, and fluorescence microscopy, we investigated primary resistance ph...

Full description

Bibliographic Details
Main Authors:	Susanne Berchtold, Julia Beil, Christian Raff, Irina Smirnow, Martina Schell, Janina D’Alvise, Silvia Gross, Ulrich M. Lauer
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Series:	International Journal of Molecular Sciences
Subjects:	oncolytic virotherapy virotherapy resistance vaccinia virus NCI-60 tumor cell panel super cytosine deaminase prodrug system chemovirotherapy
Online Access:	https://www.mdpi.com/1422-0067/21/20/7618

Similar Items

Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
by: Dobrin D. Draganov, et al.
Published: (2019-03-01)

In Vitro Sensitivity of Neuroendocrine Neoplasms to an Armed Oncolytic Measles Vaccine Virus
by: Nikolai V. Scheicher, et al.
Published: (2024-01-01)

Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review
by: Mengyuan Li, et al.
Published: (2023-09-01)

Design Strategies and Precautions for Using Vaccinia Virus in Tumor Virotherapy
by: Xinjun Liu, et al.
Published: (2022-09-01)

Oncolytic vaccinia virus and cancer immunotherapy
by: Lihua Xu, et al.
Published: (2024-01-01)

Viruses as nanomedicine for cancer
by: Badrinath N, et al.
Published: (2016-09-01)

Efficacy and Safety of Doubly-Regulated Vaccinia Virus in a Mouse Xenograft Model of Multiple Myeloma
by: Muneyoshi Futami, et al.
Published: (2017-09-01)

Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs
by: Jérémy Béguin, et al.
Published: (2020-08-01)

Overcoming Tumor Resistance to Oncolyticvaccinia Virus with Anti-PD-1-Based Combination Therapy by Inducing Antitumor Immunity in the Tumor Microenvironment
by: So Young Yoo, et al.
Published: (2020-06-01)

Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo Peritoneal Carcinomatosis Model
by: Jana Koch, et al.
Published: (2023-01-01)

Vaccinia virus and peptide-receptor radiotherapy synergize to improve treatment of peritoneal carcinomatosis
by: Kathryn Ottolino-Perry, et al.
Published: (2023-06-01)

Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus
by: Claudia Hill, et al.
Published: (2021-06-01)

Efficacy of Different Oncolytic Vaccinia Virus Strains for the Treatment of Murine Peritoneal Mesothelioma
by: Can Yurttas, et al.
Published: (2024-01-01)

A Three-Dimensional Organoid Model of Primary Breast Cancer to Investigate the Effects of Oncolytic Virotherapy
by: Mary E. Carter, et al.
Published: (2022-02-01)

Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells
by: Wang Huiqiang, et al.
Published: (2012-08-01)

Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer
by: Jérémy Béguin, et al.
Published: (2020-12-01)

A comparative study of replicative properties of antitumor recombinant vaccinia viruses on human glioblastoma cell culture U87 and monkey kidney cell culture CV-1
by: R. A. Maksyutov, et al.
Published: (2017-02-01)

Oncolytic Efficacy of a Recombinant Vaccinia Virus Strain Expressing Bacterial Flagellin in Solid Tumor Models
by: Yasmin Shakiba, et al.
Published: (2023-03-01)

Antitumor efficacy of cytosine deaminase-armed vaccinia virus plus 5-fluorocytosine in colorectal cancers
by: Yuedi Ding, et al.
Published: (2020-06-01)

Oncolytic Adenoviruses in Cancer Treatment
by: Ramon Alemany
Published: (2014-02-01)

From Benchtop to Bedside: A Review of Oncolytic Virotherapy
by: Audrey H. Choi, et al.
Published: (2016-08-01)

To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses
by: Kevin A. Cassady, et al.
Published: (2016-02-01)

Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy
by: Mohsen Keshavarz, et al.
Published: (2019-06-01)

Oncolytic viruses for the treatment of malignant glioma
by: Hong⁃yu LIU, et al.
Published: (2020-02-01)

Measles to the Rescue: A Review of Oncolytic Measles Virus
by: Sarah Aref, et al.
Published: (2016-10-01)

Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy
by: Simona Ruxandra Volovat, et al.
Published: (2024-01-01)

Modelling the spatiotemporal dynamics of chemovirotherapy cancer treatment
by: Joseph Malinzi, et al.
Published: (2017-01-01)

Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development
by: Tiffany Y. Ho, et al.
Published: (2021-09-01)

Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors
by: Jérémy Béguin, et al.
Published: (2023-09-01)

Transcriptome Changes in Glioma Cells upon Infection with the Oncolytic Virus VV-GMCSF-Lact
by: Dmitriy V. Semenov, et al.
Published: (2023-11-01)

Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus
by: Gabriel Scheubeck, et al.
Published: (2019-07-01)

Enhancing oncolytic virotherapy of glioblastoma by targeting innate immune ligands with a bispecific T cell engager
by: Baugh, R
Published: (2022)

Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
by: Valentina Marchica, et al.
Published: (2021-02-01)

Oncolytic Virotherapy in Glioma Tumors
by: Sergio Rius-Rocabert, et al.
Published: (2020-10-01)

Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma
by: Mason J. Webb, et al.
Published: (2023-05-01)

The role of viruses in cancer development versus cancer therapy: An oncological perspective
by: Hossein Javid, et al.
Published: (2023-05-01)

Virus-Based Immunotherapy of Glioblastoma
by: Miika Martikainen, et al.
Published: (2019-02-01)

Combining of Oncolytic Virotherapy and Other Immunotherapeutic Approaches in Cancer: A Powerful Functionalization Tactic
by: Hai Zou, et al.
Published: (2023-01-01)

Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study
by: Ravi N. Samy, et al.
Published: (2019-10-01)

The Continued Promise and Many Disappointments of Oncolytic Virotherapy in Gastrointestinal Malignancies
by: Daniel H. Ahn, et al.
Published: (2017-03-01)